Broader participation is crucial for improving cancer outcomes for several reasons: 1. Diversity in Research: Including diverse populations in clinical trials and research studies ensures that findings are applicable to a broad spectrum of people. 2. Patient-Centered Care: Engaging patients in decision-making processes helps tailor treatments to individual needs and preferences. 3. Equity: Ensuring that all groups have access to cutting-edge cancer treatments and preventive measures helps address disparities in cancer care.
